Back to News
    September 22, 2026

    BiotechExec Places Mark Benedyk, PhD in Two Senior Advisor Roles

    Placement announcement congratulating Mark Benedyk on Senior Advisor roles with Olfax Medical and Rogue MitoTherapeutics

    SEPTEMBER 22, 2026

    Congratulations to Mark Benedyk, PhD on his Senior Advisor placements with Olfax Medical and Rogue MitoTherapeutics.

    Two companies, two mandates, one executive. BiotechExec Ignite CXOs can hold multiple fractional engagements at once, putting senior life sciences experience to work across growing companies while creating capital efficiency for clients and maximum effectiveness for the executive.

    Rogue MitoTherapeutics

    Mark is advising Rogue on portfolio strategy for its pipeline of mitochondrial-targeting drugs for the treatment of multiple neurodegenerative diseases.

    Olfax Medical

    Olfax has pioneered a unique product for the treatment of cluster headache and other trigeminal-mediated pain syndromes. Mark is advising on strategy in preparation for its Series A fundraise.

    Two roles. One Ignite executive.

    Placements by BiotechExec: Identified and placed through the Ignite Network.